FOXK1 and esophageal squamous cell carcinoma: ESCC patients with low expression levels of FOXK1 (34/105, 32.4%) had better survival rates than those with high expression levels of FOXK1 (71/105, 67.6%) (P = 0.001) (Fig. 1e).